US Stock MarketDetailed Quotes

CLPT ClearPoint Neuro

Watchlist
  • 15.740
  • -1.480-8.59%
Trading Feb 27 11:51 ET
434.93MMarket Cap-22.49P/E (TTM)

ClearPoint Neuro Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.77%-8.95M
-6.33%-1.24M
33.24%-1.2M
47.43%-2.67M
32.39%-3.84M
15.14%-13.72M
61.86%-1.17M
53.37%-1.8M
-1.89%-5.08M
-33.05%-5.68M
Net income from continuing operations
14.37%-18.91M
-16.61%-5.39M
-3.43%-4.97M
37.49%-4.41M
26.08%-4.15M
-34.40%-22.09M
-5.34%-4.62M
-26.95%-4.81M
-63.89%-7.05M
-41.68%-5.61M
Depreciation and amortization
30.61%1.9M
11.08%471K
17.02%495K
36.58%463K
74.91%474K
87.52%1.46M
177.12%424K
148.82%423K
44.26%339K
23.74%271K
Other non cash items
173.91%51K
--0
57.14%22K
132.56%14K
127.27%15K
69.87%-69K
113.51%15K
111.48%14K
-377.78%-43K
-523.08%-55K
Change In working capital
492.98%1.4M
57.95%1.76M
149.36%1.35M
30.36%-172K
12.69%-1.54M
91.70%-356K
749.62%1.11M
145.06%543K
86.54%-247K
-27.90%-1.77M
-Change in receivables
33.15%-1.21M
8.14%-1.05M
-441.89%-401K
-49.01%-602K
559.78%846K
-754.98%-1.8M
-248.12%-1.14M
-489.47%-74K
65.05%-404K
-218.71%-184K
-Change in inventory
-40.37%743K
-68.57%309K
346.15%754K
-155.51%-373K
109.17%53K
128.18%1.25M
189.12%983K
111.03%169K
174.17%672K
34.32%-578K
-Change in prepaid assets
331.86%262K
149.15%174K
-43.74%382K
-15.91%-459K
492.86%165K
90.71%-113K
-436.36%-354K
585.00%679K
65.20%-396K
-132.81%-42K
-Change in payables and accrued expense
578.43%3.11M
363.10%1.73M
187.31%647K
144.76%1.66M
2.92%-931K
-140.79%-649K
11.31%374K
-228.65%-741K
-50.62%677K
-38.58%-959K
-Change in other current assets
-277.27%-39K
--1K
-102.13%-1K
--0
---39K
466.67%22K
--0
4,600.00%47K
---25K
--0
-Change in other current liabilities
-15.10%-869K
-15.84%-234K
10.00%-234K
-56.46%-230K
-17.12%-171K
-39.56%-755K
-43.26%-202K
-87.05%-260K
-10.53%-147K
-14.06%-146K
-Change in other working capital
-135.18%-597K
-43.26%825K
-71.37%207K
73.56%-165K
-1,116.67%-1.46M
229.51%1.7M
291.91%1.45M
7,130.00%723K
-591.34%-624K
1,957.14%144K
Cash from discontinued investing activities
Operating cash flow
34.77%-8.95M
-6.33%-1.24M
33.24%-1.2M
47.43%-2.67M
32.39%-3.84M
15.14%-13.72M
61.86%-1.17M
53.37%-1.8M
-1.89%-5.08M
-33.05%-5.68M
Investing cash flow
Cash flow from continuing investing activities
-103.07%-275K
-39.89%-263K
94.89%-12K
0
0
183.36%8.95M
-101.60%-188K
62.76%-235K
143.89%9.51M
25.41%-138K
Net PPE purchase and sale
61.65%-275K
-1,152.38%-263K
94.89%-12K
--0
--0
-183.40%-717K
46.15%-21K
-240.58%-235K
-325.00%-323K
-100.00%-138K
Net intangibles purchase and sale
--0
--0
--0
----
----
62.60%-334K
22.33%-167K
--0
----
----
Net investment purchase and sale
--0
--0
--0
----
----
204.28%10M
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-103.07%-275K
-39.89%-263K
94.89%-12K
--0
--0
183.36%8.95M
-101.60%-188K
62.76%-235K
143.89%9.51M
25.41%-138K
Financing cash flow
Cash flow from continuing financing activities
1,990.88%6.19M
-76.13%37K
-10,956.04%-10.06M
-32.49%160K
321,160.00%16.05M
-27.63%296K
-30.18%155K
72.34%-91K
-53.80%237K
-266.67%-5K
Net issuance payments of debt
---10M
--0
----
----
----
----
----
----
----
----
Net common stock issuance
--16.15M
---34K
--0
--0
--16.18M
----
----
--0
--0
--0
Proceeds from stock option exercised by employees
-8.30%464K
-19.27%155K
--0
-8.28%288K
--21K
-32.08%506K
-13.51%192K
--0
-38.79%314K
--0
Net other financing activities
-101.90%-424K
-127.03%-84K
32.97%-61K
-66.23%-128K
-2,920.00%-151K
37.50%-210K
---37K
---91K
---77K
---5K
Cash from discontinued financing activities
Financing cash flow
1,990.88%6.19M
-76.13%37K
-10,956.04%-10.06M
-32.49%160K
321,160.00%16.05M
-27.63%296K
-30.18%155K
72.34%-91K
-53.80%237K
-266.67%-5K
Net cash flow
Beginning cash position
-16.20%23.14M
-11.38%21.57M
24.11%32.85M
62.23%35.35M
-16.20%23.14M
-48.96%27.62M
30.09%24.34M
12.50%26.46M
-56.12%21.79M
-48.96%27.62M
Current changes in cash
32.16%-3.04M
-22.21%-1.47M
-431.20%-11.27M
-153.68%-2.51M
309.74%12.21M
83.11%-4.48M
-113.50%-1.2M
55.90%-2.12M
117.88%4.67M
-30.82%-5.82M
End cash Position
-13.12%20.1M
-13.12%20.1M
-11.38%21.57M
24.11%32.85M
62.23%35.35M
-16.20%23.14M
-16.20%23.14M
30.09%24.34M
12.50%26.46M
-56.12%21.79M
Free cash flow
37.55%-9.23M
-10.98%-1.51M
40.37%-1.21M
52.06%-2.67M
34.00%-3.84M
14.68%-14.77M
59.11%-1.36M
54.70%-2.03M
-10.05%-5.57M
-30.62%-5.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.77%-8.95M-6.33%-1.24M33.24%-1.2M47.43%-2.67M32.39%-3.84M15.14%-13.72M61.86%-1.17M53.37%-1.8M-1.89%-5.08M-33.05%-5.68M
Net income from continuing operations 14.37%-18.91M-16.61%-5.39M-3.43%-4.97M37.49%-4.41M26.08%-4.15M-34.40%-22.09M-5.34%-4.62M-26.95%-4.81M-63.89%-7.05M-41.68%-5.61M
Depreciation and amortization 30.61%1.9M11.08%471K17.02%495K36.58%463K74.91%474K87.52%1.46M177.12%424K148.82%423K44.26%339K23.74%271K
Other non cash items 173.91%51K--057.14%22K132.56%14K127.27%15K69.87%-69K113.51%15K111.48%14K-377.78%-43K-523.08%-55K
Change In working capital 492.98%1.4M57.95%1.76M149.36%1.35M30.36%-172K12.69%-1.54M91.70%-356K749.62%1.11M145.06%543K86.54%-247K-27.90%-1.77M
-Change in receivables 33.15%-1.21M8.14%-1.05M-441.89%-401K-49.01%-602K559.78%846K-754.98%-1.8M-248.12%-1.14M-489.47%-74K65.05%-404K-218.71%-184K
-Change in inventory -40.37%743K-68.57%309K346.15%754K-155.51%-373K109.17%53K128.18%1.25M189.12%983K111.03%169K174.17%672K34.32%-578K
-Change in prepaid assets 331.86%262K149.15%174K-43.74%382K-15.91%-459K492.86%165K90.71%-113K-436.36%-354K585.00%679K65.20%-396K-132.81%-42K
-Change in payables and accrued expense 578.43%3.11M363.10%1.73M187.31%647K144.76%1.66M2.92%-931K-140.79%-649K11.31%374K-228.65%-741K-50.62%677K-38.58%-959K
-Change in other current assets -277.27%-39K--1K-102.13%-1K--0---39K466.67%22K--04,600.00%47K---25K--0
-Change in other current liabilities -15.10%-869K-15.84%-234K10.00%-234K-56.46%-230K-17.12%-171K-39.56%-755K-43.26%-202K-87.05%-260K-10.53%-147K-14.06%-146K
-Change in other working capital -135.18%-597K-43.26%825K-71.37%207K73.56%-165K-1,116.67%-1.46M229.51%1.7M291.91%1.45M7,130.00%723K-591.34%-624K1,957.14%144K
Cash from discontinued investing activities
Operating cash flow 34.77%-8.95M-6.33%-1.24M33.24%-1.2M47.43%-2.67M32.39%-3.84M15.14%-13.72M61.86%-1.17M53.37%-1.8M-1.89%-5.08M-33.05%-5.68M
Investing cash flow
Cash flow from continuing investing activities -103.07%-275K-39.89%-263K94.89%-12K00183.36%8.95M-101.60%-188K62.76%-235K143.89%9.51M25.41%-138K
Net PPE purchase and sale 61.65%-275K-1,152.38%-263K94.89%-12K--0--0-183.40%-717K46.15%-21K-240.58%-235K-325.00%-323K-100.00%-138K
Net intangibles purchase and sale --0--0--0--------62.60%-334K22.33%-167K--0--------
Net investment purchase and sale --0--0--0--------204.28%10M--0--0--------
Cash from discontinued investing activities
Investing cash flow -103.07%-275K-39.89%-263K94.89%-12K--0--0183.36%8.95M-101.60%-188K62.76%-235K143.89%9.51M25.41%-138K
Financing cash flow
Cash flow from continuing financing activities 1,990.88%6.19M-76.13%37K-10,956.04%-10.06M-32.49%160K321,160.00%16.05M-27.63%296K-30.18%155K72.34%-91K-53.80%237K-266.67%-5K
Net issuance payments of debt ---10M--0--------------------------------
Net common stock issuance --16.15M---34K--0--0--16.18M----------0--0--0
Proceeds from stock option exercised by employees -8.30%464K-19.27%155K--0-8.28%288K--21K-32.08%506K-13.51%192K--0-38.79%314K--0
Net other financing activities -101.90%-424K-127.03%-84K32.97%-61K-66.23%-128K-2,920.00%-151K37.50%-210K---37K---91K---77K---5K
Cash from discontinued financing activities
Financing cash flow 1,990.88%6.19M-76.13%37K-10,956.04%-10.06M-32.49%160K321,160.00%16.05M-27.63%296K-30.18%155K72.34%-91K-53.80%237K-266.67%-5K
Net cash flow
Beginning cash position -16.20%23.14M-11.38%21.57M24.11%32.85M62.23%35.35M-16.20%23.14M-48.96%27.62M30.09%24.34M12.50%26.46M-56.12%21.79M-48.96%27.62M
Current changes in cash 32.16%-3.04M-22.21%-1.47M-431.20%-11.27M-153.68%-2.51M309.74%12.21M83.11%-4.48M-113.50%-1.2M55.90%-2.12M117.88%4.67M-30.82%-5.82M
End cash Position -13.12%20.1M-13.12%20.1M-11.38%21.57M24.11%32.85M62.23%35.35M-16.20%23.14M-16.20%23.14M30.09%24.34M12.50%26.46M-56.12%21.79M
Free cash flow 37.55%-9.23M-10.98%-1.51M40.37%-1.21M52.06%-2.67M34.00%-3.84M14.68%-14.77M59.11%-1.36M54.70%-2.03M-10.05%-5.57M-30.62%-5.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Collegium Pharmaceutical
COLL
+1.06%
Halozyme Therapeutics
HALO
+1.02%
Precision Drilling
PDS
+0.80%
Hutchmed (China)
HCM
+0.36%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
0.00%

Unlock the Full List

Investment Theme Brain-Computer Interface
Brain-Computer Interface
Intraday-2.44%